A quantitative measure of treatment response in recent‐onset type 1 diabetes

por Bundy, Brian N., Krischer, Jeffrey P.
Publicado 2020

The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes

por Bingley, Polly J., Boulware, David C., Krischer, Jeffrey P.
Publicado 2015

Feature ranking based on synergy networks to identify prognostic markers in DPT-1

por Adl, Amin Ahmadi, Qian, Xiaoning, Xu, Ping, Vehik, Kendra, Krischer, Jeffrey P
Publicado 2013

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes

por Xu, Ping, Qian, Xiaoning, Schatz, Desmond A., Cuthbertson, David, Krischer, Jeffrey P.
Publicado 2014

A Rule-Based Prognostic Model for Type 1 Diabetes by Identifying and Synthesizing Baseline Profile Patterns

por Lin, Ying, Qian, Xiaoning, Krischer, Jeffrey, Vehik, Kendra, Lee, Hye-Seung, Huang, Shuai
Publicado 2014

Thyroid function in the etiology of fatigue in breast cancer

por Kumar, Nagi B., Fink, Angelina, Levis, Silvina, Xu, Ping, Tamura, Roy, Krischer, Jeffrey
Publicado 2018

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial

por Vehik, Kendra, Cuthbertson, David, Ruhlig, Holly, Schatz, Desmond A., Peakman, Mark, Krischer, Jeffrey P.
Publicado 2011

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis

por Xu, Ping, Beam, Craig A., Cuthbertson, David, Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P.
Publicado 2012

A robust and transformation-free joint model with matching and regularization for metagenomic trajectory and disease onset

por Li, Qian, Vehik, Kendra, Li, Cai, Triplett, Eric, Roesch, Luiz, Hu, Yi-Juan, Krischer, Jeffrey
Publicado 2022

ISLET: individual-specific reference panel recovery improves cell-type-specific inference

por Feng, Hao, Meng, Guanqun, Lin, Tong, Parikh, Hemang, Pan, Yue, Li, Ziyi, Krischer, Jeffrey, Li, Qian
Publicado 2023

Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study

por Applequist, Janelle, Burroughs, Cristina, Merkel, Peter A, Rothenberg, Marc, Trapnell, Bruce, Desnick, Robert, Sahin, Mustafa, Krischer, Jeffrey
Publicado 2023

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Palmer, Jerry P., Rafkin-Mervis, Lisa, Krischer, Jeffrey P., Cuthbertson, David, Matheson, Della, Skyler, Jay S.
Publicado 2008

The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network

por Merkel, Peter A., Manion, Michele, Gopal-Srivastava, Rashmi, Groft, Stephen, Jinnah, H. A., Robertson, David, Krischer, Jeffrey P.
Publicado 2016

Type 1 Diabetes Risk Phenotypes Using Cluster Analysis

por You, Lu, Ferrat, Lauric A., Oram, Richard A., Parikh, Hemang M., Steck, Andrea K., Krischer, Jeffrey, Redondo, Maria J.
Publicado 2023

Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes

por Xu, Ping, Wu, Yougui, Zhu, Yiliang, Dagne, Getachew, Johnson, Giffe, Cuthbertson, David, Krischer, Jeffrey P., Sosenko, Jay M., Skyler, Jay S.
Publicado 2010

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood

por Vehik, Kendra, Haller, Michael J., Beam, Craig A., Schatz, Desmond A., Wherrett, Diane K., Sosenko, Jay M., Krischer, Jeffrey P.
Publicado 2011

SARS-CoV-2 — No Increased Islet Autoimmunity or Type 1 Diabetes in Teens

por Krischer, Jeffrey P., Lernmark, Åke, Hagopian, William A., Rewers, Marian J., McIndoe, Richard, Toppari, Jorma, Ziegler, Anette-Gabriele, Akolkar, Beena
Publicado 2023

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

por Sosenko, Jay M., Palmer, Jerry P., Rafkin, Lisa E., Krischer, Jeffrey P., Cuthbertson, David, Greenbaum, Carla J., Eisenbarth, George, Skyler, Jay S.
Publicado 2010

Development of Autoantibodies in the TrialNet Natural History Study

por Vehik, Kendra, Beam, Craig A., Mahon, Jeffrey L., Schatz, Desmond A., Haller, Michael J., Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P.
Publicado 2011

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants

por Sosenko, Jay M., Skyler, Jay S., Palmer, Jerry P., Krischer, Jeffrey P., Cuthbertson, David, Yu, Liping, Schatz, Desmond A., Orban, Tihamer, Eisenbarth, George
Publicado 2011